p.115 抽出テキスト

patients with multivessel coronary artery disease. JAMA Netw Open 2020;3:e2012749. https://doi.org/10.1001/jamanetworkopen.2020.12749 859. Dzavik V, Ghali WA, Norris C, Mitchell LB, Koshal A, Saunders LD, et al. Long-term survival in 11,661 patients with multivessel coronary artery disease in the era of stenting: a report from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) investigators. Am Heart J 2001;142:119–26. https://doi.org/10.1067/mhj.2001.116072 860. Lee PH, Ahn JM, Chang M, Baek S, Yoon SH, Kang SJ, et al. Left main coronary artery disease: secular trends in patient characteristics, treatments, and outcomes. J Am Coll Cardiol 2016;68:1233–46. https://doi.org/10.1016/j.jacc.2016.05.089 861. Panza JA, Velazquez EJ, She L, Smith PK, Nicolau JC, Favaloro RR, et al. Extent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV dysfunction [Corrected]. J Am Coll Cardiol 2014;64:553–61. https://doi.org/10.1016/j. jacc.2014.04.064 862. Sullivan PG, Wallach JD, Ioannidis JP. Meta-analysis comparing established risk prediction models (EuroSCORE II, STS Score, and ACEF Score) for perioperative mortality during cardiac surgery. Am J Cardiol 2016;118:1574–82. https://doi.org/10.1016/j. amjcard.2016.08.024 863. Ad N, Holmes SD, Patel J, Pritchard G, Shuman DJ, Halpin L. Comparison of EuroSCORE II, original EuroSCORE, and the Society of Thoracic Surgeons Risk Score in cardiac surgery patients. Ann Thorac Surg 2016;102:573–9. https://doi.org/ 10.1016/j.athoracsur.2016.01.105 864. Sinha S, Dimagli A, Dixon L, Gaudino M, Caputo M, Vohra HA, et al. Systematic review and meta-analysis of mortality risk prediction models in adult cardiac surgery. Interact Cardiovasc Thorac Surg 2021;33:673–86. https://doi.org/10.1093/icvts/ivab151 865. Scudeler TL, Farkouh ME, Hueb W, Rezende PC, Campolina AG, Martins EB, et al. Coronary atherosclerotic burden assessed by SYNTAX scores and outcomes in surgical, percutaneous or medical strategies: a retrospective cohort study. BMJ Open 2022;12:e062378. https://doi.org/10.1136/bmjopen-2022-062378 866. Kuno T, Kiyohara Y, Maehara A, Ueyama HA, Kampaktsis PN, Takagi H, et al. Comparison of intravascular imaging, functional, or angiographically guided coronary intervention. J Am Coll Cardiol 2023;82:2167–76. https://doi.org/10.1016/j.jacc.2023. 09.823 867. Chen H, Hong L, Xi G, Wang H, Hu J, Liu Q, et al. Prognostic value of quantitative flow ratio in patients with coronary heart disease after percutaneous coronary intervention therapy: a meta-analysis. Front Cardiovasc Med 2023;10:1164290. https://doi.org/10. 3389/fcvm.2023.1164290 868. Agarwal SK, Kasula S, Hacioglu Y, Ahmed Z, Uretsky BF, Hakeem A. Utilizing postintervention fractional flow reserve to optimize acute results and the relationship to long-term outcomes. JACC Cardiovasc Interv 2016;9:1022–31. https://doi.org/10.1016/ j.jcin.2016.01.046 869. Milojevic M, Serruys PW, Sabik JF, Kandzari DE, Schampaert E, van Boven AJ, et al. Bypass surgery or stenting for left main coronary artery disease in patients with diabetes. J Am Coll Cardiol 2019;73:1616–28. https://doi.org/10.1016/j.jacc.2019.01.037 870. Gaudino M, Audisio K, Hueb WA, Stone GW, Farkouh ME, Di Franco A, et al. Coronary artery bypass grafting versus medical therapy in patients with stable coronary artery disease: an individual patient data pooled meta-analysis of randomized trials. J Thorac Cardiovasc Surg 2024;167:1022–32.e14. https://doi.org/10.1016/j.jtcvs.2022. 06.003 871. Bari 2D Study Group; Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009;360:2503–15. https://doi.org/10.1056/NEJMoa0805796 872. Park DW, Kim YH, Song HG, Ahn JM, Kim WJ, Lee JY, et al. Long-term outcome of stents versus bypass surgery in diabetic and nondiabetic patients with multivessel or left main coronary artery disease: a pooled analysis of 5775 individual patient data. Circ Cardiovasc Interv 2012;5:467–75. https://doi.org/10.1161/circinterventions.112. 969915 873. Kamalesh M, Sharp TG, Tang XC, Shunk K, Ward HB, Walsh J, et al. Percutaneous coronary intervention versus coronary bypass surgery in United States veterans with diabetes. J Am Coll Cardiol 2013;61:808–16. https://doi.org/10.1016/j.jacc.2012.11.044 874. Kappetein AP, Head SJ, Morice MC, Banning AP, Serruys PW, Mohr FW, et al. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur J Cardiothorac Surg 2013;43:1006–13. https://doi.org/10.1093/ejcts/ ezt017 875. Booth J, Clayton T, Pepper J, Nugara F, Flather M, Sigwart U, et al. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS). Circulation 2008;118:381–8. https://doi.org/10.1161/ circulationaha.107.739144 876. Park SJ, Ahn JM, Kim YH, Park DW, Yun SC, Lee JY, et al. Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med 2015;372:1204–12. https:// doi.org/10.1056/NEJMoa1415447 877. Hueb WA, Bellotti G, de Oliveira SA, Arie S, de Albuquerque CP, Jatene AD, et al. The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol 1995;26:1600–5. https://doi.org/10.1016/ 0735-1097(95)00384-3 878. Aziz O, Rao C, Panesar SS, Jones C, Morris S, Darzi A, et al. Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery. BMJ 2007;334:617. https://doi.org/ 10.1136/bmj.39106.476215.BE 879. Deppe A-C, Liakopoulos OJ, Kuhn EW, Slottosch I, Scherner M, Choi YH, et al. Minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for single-vessel disease: a meta-analysis of 2885 patients. Eur J Cardiothorac Surg 2015;47:397–406. https://doi.org/10.1093/ejcts/ezu285 880. Crespo-Leiro MG, Anker SD, Maggioni AP, Coats AJ, Filippatos G, Ruschitzka F, et al. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail 2016;18: 613–25. https://doi.org/10.1002/ejhf.566 881. Fox KF, Cowie MR, Wood DA, Coats AJ, Gibbs JS, Underwood SR, et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J 2001;22:228–36. https://doi.org/10.1053/euhj.2000.2289 882. Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail 2020;22:1342–56. https://doi.org/10.1002/ejhf.1858 883. Shah SJ, Lam CSP, Svedlund S, Saraste A, Hage C, Tan RS, et al. Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF. Eur Heart J 2018;39:3439–50. https://doi.org/10.1093/ eurheartj/ehy531 884. Yang JH, Obokata M, Reddy YNV, Redfield MM, Lerman A, Borlaug BA. Endothelium-dependent and independent coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. Eur J Heart Fail 2020;22: 432–41. https://doi.org/10.1002/ejhf.1671 885. Sinha A, Rahman H, Webb A, Shah AM, Perera D. Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction. Eur Heart J 2021;42:4431–41. https://doi.org/10.1093/eurheartj/ehab653 886. Crea F, Bairey Merz CN, Beltrame JF, Kaski JC, Ogawa H, Ong P, et al. The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift. Eur Heart J 2017;38:473–7. https://doi.org/10.1093/eurheartj/ehw461 887. Rush CJ, Berry C, Oldroyd KG, Rocchiccioli JP, Lindsay MM, Touyz RM, et al. Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. JAMA Cardiol 2021;6: 1130–43. https://doi.org/10.1001/jamacardio.2021.1825 888. Arnold JR, Kanagala P, Budgeon CA, Jerosch-Herold M, Gulsin G, Singh A, et al. Prevalence and prognostic significance of microvascular dysfunction in heart failure with preserved ejection fraction. JACC Cardiovasc Imaging 2022;15:1001–11. https:// doi.org/10.1016/j.jcmg.2021.11.022 889. Lin X, Wu G, Wang S, Huang J. The prevalence of coronary microvascular dysfunction (CMD) in heart failure with preserved ejection fraction (HFpEF): a systematic review and meta-analysis. Heart Fail Rev 2024;29:405–16. https://doi.org/10.1007/s10741- 023-10362-x 890. Paolisso P, Gallinoro E, Belmonte M, Bertolone DT, Bermpeis K, De Colle C, et al. Coronary microvascular dysfunction in patients with heart failure: characterization of patterns in HFrEF versus HFpEF. Circ Heart Fail 2023;17:e010805. https://doi.org/ 10.1161/circheartfailure.123.010805 891. Taqueti VR, Solomon SD, Shah AM, Desai AS, Groarke JD, Osborne MT, et al. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J 2018;39:840–9. https://doi.org/10.1093/eurheartj/ehx721 892. Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 2013;62:263–71. https:// doi.org/10.1016/j.jacc.2013.02.092 893. Sicari R, Nihoyannopoulos P, Evangelista A, Kasprzak J, Lancellotti P, Poldermans D, et al. Stress echocardiography expert consensus statement—executive summary: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur Heart J 2009;30:278–89. https://doi.org/10.1093/eurheartj/ehn492 894. Garbi M, McDonagh T, Cosyns B, Bucciarelli-Ducci C, Edvardsen T, Kitsiou A, et al. Appropriateness criteria for cardiovascular imaging use in heart failure: report of literature review. Eur Heart J Cardiovasc Imaging 2015;16:147–53. https://doi.org/10.1093/ ehjci/jeu299 895. Ghostine S, Caussin C, Habis M, Habib Y, Clement C, Sigal-Cinqualbre A, et al. Non-invasive diagnosis of ischaemic heart failure using 64-slice computed tomography. Eur Heart J 2008;29:2133–40. https://doi.org/10.1093/eurheartj/ehn072 896. Andreini D, Pontone G, Bartorelli AL, Agostoni P, Mushtaq S, Bertella E, et al. Sixty-four-slice multidetector computed tomography: an accurate imaging modality for the evaluation of coronary arteries in dilated cardiomyopathy of unknown etiology. Circ Cardiovasc Imaging 2009;2:199–205. https://doi.org/10.1161/circimaging.108. 822809 897. van den Boogert TPW, Claessen B, van Randen A, van Schuppen J, Boekholdt SM, Beijk MAM, et al. Implementation of CT coronary angiography as an alternative to invasive coronary angiography in the diagnostic work-up of non-coronary cardiac surgery,

ESC Guidelines                                                                                                                                                                                          3529

Downloaded from academic.oup.com/eurheartj/article/45/36/3415/7743115 by guest on 07 October 2026